tiprankstipranks
Genor Biopharma Holdings Limited (DE:67N0)
FRANKFURT:67N0
Germany Market
67N0
Genor Biopharma Holdings Limited
RESEARCH TOOLSreports

Genor Biopharma Holdings Limited (67N0) Financial Statements

0 Followers

Genor Biopharma Holdings Limited Financial Overview

Genor Biopharma Holdings Limited's market cap is currently €373.28M. The company's EPS TTM is €0.2358; its P/E ratio is 4.70; Genor Biopharma Holdings Limited is scheduled to report earnings on August 28, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 2.70B¥ 2.76B¥ 0.00¥ 18.53M¥ 0.00
Gross Profit¥ 1.76B¥ 1.78B¥ -84.96M¥ -45.04M¥ -73.21M
Operating Income¥ 689.46M¥ 713.61M¥ -771.77M¥ -914.26M¥ -1.11B
EBITDA¥ 954.29M¥ 924.14M¥ -686.81M¥ -851.84M¥ -1.03B
Net Income¥ 433.01M¥ 420.56M¥ -745.17M¥ -849.15M¥ -1.04B
Balance Sheet
Cash & Short-Term Investments¥ 1.06B¥ 1.06B¥ 1.17B¥ 1.59B¥ 2.20B
Total Assets¥ 6.61B¥ 1.29B¥ 1.45B¥ 2.12B¥ 2.86B
Total Debt¥ 1.49B¥ 911.00K¥ 7.16M¥ 28.59M¥ 57.41M
Net Debt¥ 431.36M¥ -1.06B¥ -1.16B¥ -1.56B¥ -2.14B
Total Liabilities¥ 2.75B¥ 138.05M¥ 256.18M¥ 309.87M¥ 369.73M
Stockholders' Equity¥ 3.86B¥ 1.15B¥ 1.19B¥ 1.80B¥ 2.49B
Cash Flow
Free Cash Flow¥ 404.05M¥ -123.55M¥ -426.15M¥ -590.56M¥ -695.13M
Operating Cash Flow¥ 451.73M¥ -121.98M¥ -425.12M¥ -577.61M¥ -623.74M
Investing Cash Flow¥ 1.24B¥ 8.01M¥ 5.99M¥ -12.94M¥ -54.26M
Financing Cash Flow¥ -744.78M¥ -1.56M¥ -6.82M¥ -57.39M¥ 17.57M
Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History

Income Statement >

Genor Biopharma Holdings Limited Debt to Assets

Balance Sheet >

Genor Biopharma Holdings Limited Cash Flow

Cash Flow >

Genor Biopharma Holdings Limited Forecast EPS vs Actual EPS

Earnings >